Barclays’s Achaogen Inc AKAO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-100
| Closed | – | – | 7492 |
|
|
2019
Q2 | $0 | Sell |
100
-9,134
| -99% | -$3.1K | ﹤0.01% | 7558 |
|
|
2019
Q1 | $4K | Sell |
9,234
-7,265
| -44% | -$7.63K | ﹤0.01% | 6782 |
|
|
2018
Q4 | $20K | Sell |
16,499
-27,464
| -62% | -$73.3K | ﹤0.01% | 5914 |
|
|
2018
Q3 | $175K | Buy |
43,963
+36,592
| +496% | +$221K | ﹤0.01% | 5115 |
|
|
2018
Q2 | $64K | Sell |
7,371
-32,725
| -82% | -$399K | ﹤0.01% | 5516 |
|
|
2018
Q1 | $520K | Buy |
40,096
+25,503
| +175% | +$289K | ﹤0.01% | 3936 |
|
|
2017
Q4 | $157K | Sell |
14,593
-16,809
| -54% | -$211K | ﹤0.01% | 4897 |
|
|
2017
Q3 | $501K | Buy |
31,402
+31,379
| +136,430% | +$597K | ﹤0.01% | 3624 |
|
|
2017
Q2 | $0 | Sell |
23
-25,687
| -100% | -$586K | ﹤0.01% | 7129 |
|
|
2017
Q1 | $649K | Buy |
25,710
+24,929
| +3,192% | +$512K | ﹤0.01% | 3146 |
|
|
2016
Q4 | $10K | Buy |
+781
| New | +$5.36K | ﹤0.01% | 5915 |
|
|
2015
Q3 | – | Sell |
-1,601
| Closed | -$10K | – | 7189 |
|
|
2015
Q2 | $10K | Buy |
1,601
+1,392
| +666% | +$8.63K | ﹤0.01% | 6111 |
|
|
2015
Q1 | $2K | Sell |
209
-2,583
| -93% | -$29.1K | ﹤0.01% | 6917 |
|
|
2014
Q4 | $36K | Buy |
2,792
+2,720
| +3,778% | +$27.7K | ﹤0.01% | 5963 |
|
|
2014
Q3 | $1K | Sell |
72
-79
| -52% | -$809 | ﹤0.01% | 7567 |
|
|
2014
Q2 | $2K | Buy |
+151
| New | +$2.12K | ﹤0.01% | 7446 |
|
Other funds holding AKAO
Barclays's AKAO Position: Q3 2019 in Review
Barclays sold out of Achaogen Inc (AKAO) in Q3 2019, closing a stake of 100 shares.
Barclays first reported a position in AKAO in Q2 2014 and held it in 16 quarters. The position peaked at $649K in Q1 2017. 3 funds tracked by Wall St. Rank hold AKAO as of Q3 2019.
- Barclays reported no remaining Achaogen Inc position as of Q3 2019 after selling out during the quarter.
- Barclays sold 100 Achaogen Inc shares in Q3 2019.
- Barclays first reported a position in Achaogen Inc in Q2 2014 and held it in 16 quarters.
- Barclays's Achaogen Inc position peaked at $649K in Q1 2017.
- 3 funds tracked by Wall St. Rank held Achaogen Inc as of Q3 2019.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.